<bill session="114" type="s" number="524" updated="2023-04-24T20:39:48Z">
  <state datetime="2016-07-22">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2016-07-22"/>
  </status>
  <introduced datetime="2015-02-12"/>
  <titles>
    <title type="display">Comprehensive Addiction and Recovery Act of 2016</title>
    <title type="official" as="enacted">An Act to authorize the Attorney General and Secretary of Health and Human Services to award grants to address the prescription opioid abuse and heroin use crisis, and for other purposes.</title>
    <title type="official" as="amended by house">To authorize the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use, and to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.</title>
    <title type="official" as="introduced">A bill to authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use.</title>
    <title type="popular">CARA bill</title>
    <title type="short" as="reported to senate">Comprehensive Addiction and Recovery Act of 2016</title>
    <title type="short" as="introduced">Comprehensive Addiction and Recovery Act of 2015</title>
    <title type="short" as="passed house" partial="1">Co-Prescribing to Reduce Overdoses Act of 2016</title>
    <title type="short" as="passed house" partial="1">Comprehensive Opioid Abuse Reduction Act of 2016</title>
    <title type="short" as="passed house" partial="1">Examining Opioid Treatment Infrastructure Act of 2016</title>
    <title type="short" as="passed house" partial="1">Good Samaritan Assessment Act of 2016</title>
    <title type="short" as="passed house" partial="1">Improving Treatment for Pregnant and Postpartum Women Act of 2016</title>
    <title type="short" as="passed house" partial="1">Infant Plan of Safe Care Improvement Act</title>
    <title type="short" as="passed house" partial="1">John Thomas Decker Act of 2016</title>
    <title type="short" as="passed house" partial="1">Kingpin Designation Improvement Act of 2016</title>
    <title type="short" as="passed house" partial="1">Lali's Law</title>
    <title type="short" as="passed house" partial="1">National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015</title>
    <title type="short" as="passed house" partial="1">Nurturing And Supporting Healthy Babies Act or the NAS Healthy Babies Act</title>
    <title type="short" as="passed house" partial="1">Opioid Program Evaluation Act or the OPEN Act</title>
    <title type="short" as="passed house" partial="1">Opioid Review Modernization Act of 2016</title>
    <title type="short" as="passed house" partial="1">Opioid Use Disorder Treatment Expansion and Modernization Act</title>
    <title type="short" as="passed house" partial="1">Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act</title>
    <title type="short" as="passed house" partial="1">Reducing Unused Medications Act of 2016</title>
    <title type="short" as="passed house" partial="1">Veteran Emergency Medical Technician Support Act of 2016</title>
    <title type="short" as="passed senate">Comprehensive Addiction and Recovery Act of 2016</title>
    <title type="short" as="passed senate" partial="1">Transnational Drug Trafficking Act of 2015</title>
    <title type="short" as="enacted">Comprehensive Addiction and Recovery Act of 2016</title>
    <title type="short" as="enacted" partial="1">Jason Simcakoski Memorial and Promise Act</title>
    <title type="short" as="conference report">Comprehensive Addiction and Recovery Act of 2016</title>
    <title type="short" as="conference report" partial="1">Jason Simcakoski Memorial and Promise Act</title>
  </titles>
  <sponsor bioguide_id="W000802"/>
  <cosponsors>
    <cosponsor bioguide_id="A000360" joined="2016-07-12"/>
    <cosponsor bioguide_id="A000368" joined="2015-02-12"/>
    <cosponsor bioguide_id="B001230" joined="2015-07-07"/>
    <cosponsor bioguide_id="B001277" joined="2015-09-29"/>
    <cosponsor bioguide_id="B000575" joined="2016-02-22"/>
    <cosponsor bioguide_id="B001288" joined="2016-03-07"/>
    <cosponsor bioguide_id="B001236" joined="2016-02-25"/>
    <cosponsor bioguide_id="C001047" joined="2016-01-21"/>
    <cosponsor bioguide_id="C000542" joined="2016-02-23"/>
    <cosponsor bioguide_id="C001035" joined="2015-04-16"/>
    <cosponsor bioguide_id="C001088" joined="2015-02-12"/>
    <cosponsor bioguide_id="C001056" joined="2016-02-22"/>
    <cosponsor bioguide_id="D000607" joined="2016-01-27"/>
    <cosponsor bioguide_id="D000563" joined="2016-02-11"/>
    <cosponsor bioguide_id="F000062" joined="2015-02-24"/>
    <cosponsor bioguide_id="F000457" joined="2015-02-24"/>
    <cosponsor bioguide_id="G000555" joined="2015-03-11"/>
    <cosponsor bioguide_id="G000359" joined="2015-05-22"/>
    <cosponsor bioguide_id="G000386" joined="2016-02-22"/>
    <cosponsor bioguide_id="H000338" joined="2015-05-20"/>
    <cosponsor bioguide_id="H001046" joined="2016-01-28"/>
    <cosponsor bioguide_id="H001042" joined="2016-02-29"/>
    <cosponsor bioguide_id="K000384" joined="2016-02-25"/>
    <cosponsor bioguide_id="K000383" joined="2015-09-21"/>
    <cosponsor bioguide_id="K000360" joined="2015-02-12"/>
    <cosponsor bioguide_id="K000367" joined="2015-02-12"/>
    <cosponsor bioguide_id="L000174" joined="2016-01-12"/>
    <cosponsor bioguide_id="M001183" joined="2015-09-28"/>
    <cosponsor bioguide_id="M001170" joined="2016-02-25"/>
    <cosponsor bioguide_id="M000639" joined="2015-09-17"/>
    <cosponsor bioguide_id="M001153" joined="2016-02-29"/>
    <cosponsor bioguide_id="N000032" joined="2015-02-24"/>
    <cosponsor bioguide_id="P000449" joined="2015-02-12"/>
    <cosponsor bioguide_id="R000595" joined="2016-02-08"/>
    <cosponsor bioguide_id="S000033" joined="2016-02-29"/>
    <cosponsor bioguide_id="S001194" joined="2016-02-24"/>
    <cosponsor bioguide_id="S000148" joined="2015-02-26"/>
    <cosponsor bioguide_id="S001181" joined="2015-09-17"/>
    <cosponsor bioguide_id="S000770" joined="2016-02-29"/>
    <cosponsor bioguide_id="S001198" joined="2016-01-28"/>
    <cosponsor bioguide_id="T000464" joined="2016-02-04"/>
    <cosponsor bioguide_id="T000476" joined="2016-02-24"/>
    <cosponsor bioguide_id="U000039" joined="2016-02-09"/>
    <cosponsor bioguide_id="W000817" joined="2015-02-24"/>
  </cosponsors>
  <actions>
    <action datetime="2015-02-12">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2015-02-12" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
    <action datetime="2016-01-27">
      <text>Committee on the Judiciary. Hearings held.</text>
    </action>
    <action datetime="2016-02-11" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2016-02-22">
      <text>Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2016-02-22" calendar="Senate Legislative" under="General Orders" number="369">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 369.</text>
    </calendar>
    <action datetime="2016-02-25">
      <text>Motion to proceed to consideration of measure made in Senate.</text>
      <reference ref="CR S1037-1038" label="consideration"/>
    </action>
    <action datetime="2016-02-25">
      <text>Cloture motion on the motion to proceed to the measure presented in Senate.</text>
      <reference ref="CR S1037-1038" label="consideration"/>
      <reference ref="CR S1037" label="text"/>
    </action>
    <action datetime="2016-02-29">
      <text>Motion to proceed to measure considered in Senate.</text>
      <reference ref="CR S1074-1080" label="consideration"/>
    </action>
    <vote-aux how="roll" type="cloture" roll="27" datetime="2016-02-29" where="s" result="pass">
      <text>Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 89 - 0. Record Vote Number: 27.</text>
      <reference ref="CR S1076" label="consideration"/>
      <reference ref="CR S1076" label="text"/>
    </vote-aux>
    <action datetime="2016-03-01">
      <text>Motion to proceed to measure considered in Senate.</text>
      <reference ref="CR S1106-1115, S1115-1132" label="consideration"/>
    </action>
    <action datetime="2016-03-02">
      <text>Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent.</text>
      <reference ref="CR S1171" label="consideration"/>
    </action>
    <action datetime="2016-03-02">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S1171-1218" label="consideration"/>
      <reference ref="CR S1171-1180" label="text of measure as reported in Senate"/>
    </action>
    <action datetime="2016-03-02">
      <text>The committee substitute withdrawn by Unanimous Consent.</text>
      <reference ref="CR S1180" label="consideration"/>
    </action>
    <action datetime="2016-03-03">
      <text>Considered by Senate.</text>
      <reference ref="CR S1245-1273" label="consideration"/>
    </action>
    <action datetime="2016-03-03">
      <text>Cloture motion on the measure presented in Senate.</text>
      <reference ref="CR S1273" label="consideration"/>
      <reference ref="CR S1273" label="text"/>
    </action>
    <action datetime="2016-03-07">
      <text>Considered by Senate.</text>
      <reference ref="CR S1303-1313" label="consideration"/>
    </action>
    <action datetime="2016-03-08">
      <text>Considered by Senate.</text>
      <reference ref="CR S1328-1332, S1332-1341" label="consideration"/>
    </action>
    <action datetime="2016-03-09">
      <text>Considered by Senate.</text>
      <reference ref="CR S1357-1384" label="consideration"/>
    </action>
    <action datetime="2016-03-09">
      <text>Cloture on the measure invoked in Senate by Yea-Nay Vote. 93 - 3. Record Vote Number: 33.</text>
      <reference ref="CR S1361" label="consideration"/>
      <reference ref="CR S1361" label="text"/>
    </action>
    <action datetime="2016-03-10">
      <text>Considered by Senate.</text>
      <reference ref="CR S1403-1416" label="consideration"/>
    </action>
    <vote how="roll" type="vote" roll="34" datetime="2016-03-10" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Yea-Nay Vote. 94 - 1. Record Vote Number: 34.</text>
      <reference ref="CR S1404-1416" label="text as passed Senate"/>
    </vote>
    <action datetime="2016-03-10">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2016-03-14T14:06:17-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2016-03-14T18:28:53-04:00">
      <text>Held at the desk.</text>
    </action>
    <action datetime="2016-05-12T16:33:41-04:00">
      <text>Rules Committee Resolution H. Res. 725 Reported to House. Rule provides for consideration of S. 524. Motion to recommit with or without instructions allowed. Bill is closed to amendments.</text>
    </action>
    <action datetime="2016-05-13T10:37:59-04:00">
      <text>Rule H. Res. 725 passed House.</text>
    </action>
    <action datetime="2016-05-13T10:44:22-04:00">
      <text>Considered under the provisions of rule H. Res. 725.</text>
      <reference ref="CR H2355-2374" label="consideration"/>
    </action>
    <action datetime="2016-05-13T10:44:27-04:00">
      <text>Rule provides for consideration of S. 524. Motion to recommit with or without instructions allowed. Bill is closed to amendments.</text>
    </action>
    <action datetime="2016-05-13T10:45:17-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on S. 524.</text>
    </action>
    <action datetime="2016-05-13T10:54:07-04:00">
      <text>DEBATE - The House continued with debate on S. 524.</text>
    </action>
    <action datetime="2016-05-13T11:29:09-04:00">
      <text>The previous question was ordered pursuant to the rule.</text>
      <reference ref="CR H2373" label="consideration"/>
    </action>
    <vote how="roll" type="vote2" roll="193" datetime="2016-05-13T11:51:38-04:00" where="h" result="pass" state="PASSED:BILL">
      <text>On passage Passed by the Yeas and Nays: 400 - 5 (Roll no. 193).</text>
      <reference ref="CR H2355-2368" label="text"/>
    </vote>
    <action datetime="2016-05-13T11:51:39-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2016-05-13T11:51:40-04:00">
      <text>The title of the measure was amended pursuant to H. Res. 725.</text>
    </action>
    <action datetime="2016-05-13T11:53:39-04:00">
      <text>Mrs. Brooks (IN) asked unanimous consent that the House insist upon its amendments, and request a conference.</text>
      <reference ref="CR H2374" label="consideration"/>
    </action>
    <action datetime="2016-05-13T11:53:40-04:00">
      <text>On motion that the House insist upon its amendments, and request a conference Agreed to without objection.</text>
    </action>
    <action datetime="2016-05-13T11:54:21-04:00">
      <text>Ms. Esty moved that the House instruct conferees.</text>
      <reference ref="CR H2374-2375" label="consideration"/>
      <reference ref="CR H2374" label="text"/>
    </action>
    <action datetime="2016-05-13T11:54:52-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on the Esty motion to instruct conferees. The instructions contained in the motion seek to require the managers on the part of the House to recede to title III of the bill (relating to treatment and recovery programs).</text>
    </action>
    <action datetime="2016-05-13T12:09:53-04:00">
      <text>The previous question was ordered without objection.</text>
      <reference ref="CR H2376" label="consideration"/>
    </action>
    <action datetime="2016-05-13T12:09:54-04:00">
      <text>POSTPONED PROCEEDINGS - The Chair put the question on adoption of the motion to instruct conferees and by voice vote, announced that the noes had prevailed. Ms. Esty demanded the yeas and nays and the Chair postponed further proceedings on the question of adoption of the motion until a time to be announced.</text>
    </action>
    <action datetime="2016-05-17T14:46:16-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H2456-2457" label="consideration"/>
    </action>
    <action datetime="2016-05-17T14:46:17-04:00">
      <text>On motion that the House instruct conferees Failed by the Yeas and Nays: 182 - 236 (Roll no. 198).</text>
    </action>
    <action datetime="2016-05-17T14:46:19-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2016-05-17T14:53:07-04:00">
      <text>The Speaker appointed conferees for consideration of the Senate bill and the House amendments, and modifications committed to conference: Upton, Pitts, Lance, Guthrie, Kinzinger of Illinois, Bucshon, Brooks of Indiana, Goodlatte, Sensenbrenner, Smith of Texas, Marino, Collins of Georgia, Trott, Bishop of Michigan, McCarthy, Pallone, Ben Ray Luj&#195;&#161;n of New Mexico, Sarbanes, Gene Green of Texas, Conyers, Jackson Lee, Judy Chu of California, Cohen, Esty, Kuster, and Courtney.</text>
    </action>
    <action datetime="2016-05-17T14:53:08-04:00">
      <text>The Speaker appointed conferees - from the Committee on Education and the Workforce for consideration of title VII of the House amendment, and modifications committed to conference: Barletta, Carter of Georgia, and Scott of Virginia.</text>
    </action>
    <action datetime="2016-05-17T14:54:00-04:00">
      <text>The Speaker appointed conferees - from the Committee on Veterans' Affairs for consideration of title III of the House amendment, and modifications committed to conference: Bilirakis, Walorski, and Ruiz.</text>
    </action>
    <action datetime="2016-05-17T14:54:01-04:00">
      <text>The Speaker appointed conferees - from the Committee on Ways and Means for consideration of sec. 705 of the Senate bill, and sec. 804 of the House amendment, and modifications committed to conference: Meehan, Dold, and McDermott.</text>
    </action>
    <action datetime="2016-05-17">
      <text>Message on House action received in Senate and at desk: House amendments to Senate bill and House requests a conference.</text>
    </action>
    <action datetime="2016-06-16">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S4277-4285" label="consideration"/>
    </action>
    <action datetime="2016-06-16">
      <text>Motion to disagree to the House amendments to the Senate bill, agree to the request for conference, and the Presiding Officer appoint the following conferees: Grassley, Alexander, Hatch, Sessions, Leahy, Murray, and Wyden made in Senate.</text>
      <reference ref="CR S4277" label="consideration"/>
    </action>
    <action datetime="2016-06-16">
      <text>Cloture motion on the motion to disagree to the House amendments to the Senate bill, agree to the request for conference, and the Presiding Officer appoint the following conferees: Grassley, Alexander, Hatch, Sessions, Leahy, Murray, and Wyden presented in Senate.</text>
      <reference ref="CR S4277" label="consideration"/>
      <reference ref="CR S4277" label="text"/>
    </action>
    <action datetime="2016-06-16">
      <text>Cloture on the motion to disagree to the House amendments to the Senate bill, agree to the request for conference, and the Presiding Officer appoint the following conferees: Grassley, Alexander, Hatch, Sessions, Leahy, Murray, and Wyden invoked in Senate by Yea-Nay Vote. 95 - 1. Record Vote Number: 100.</text>
      <reference ref="CR S4283" label="consideration"/>
      <reference ref="CR S4283" label="text"/>
    </action>
    <action datetime="2016-06-16">
      <text>Motion to disagree to the House amendments to the Senate bill, agree to the request for conference, and the Presiding Officer appoint the following conferees: Grassley, Alexander, Hatch, Sessions, Leahy, Murray, and Wyden agreed to in Senate by Voice Vote.</text>
    </action>
    <action datetime="2016-06-16">
      <text>Senate disagrees to the House amendments to the Senate bill, agrees to the request for conference, and the Presiding Officer appoints the following conferees: Grassley, Alexander, Hatch, Sessions, Leahy, Murray, and Wyden.</text>
    </action>
    <action datetime="2016-06-16">
      <text>Motion by Senator Shaheen to instruct Senate conferees agreed to in Senate by Yea-Nay Vote. 66 - 29. Record Vote Number: 101.</text>
      <reference ref="CR S4284" label="consideration"/>
      <reference ref="CR S4284" label="text"/>
    </action>
    <action datetime="2016-06-16">
      <text>Motion by Senator Whitehouse to instruct Senate conferees agreed to in Senate by Yea-Nay Vote. 70 - 24. Record Vote Number: 102.</text>
      <reference ref="CR S4284" label="consideration"/>
      <reference ref="CR S4284" label="text"/>
    </action>
    <action datetime="2016-06-16">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2016-07-06T19:00:00-04:00">
      <text>Conferees agreed to file conference report.</text>
    </action>
    <action datetime="2016-07-06T19:13:46-04:00">
      <text>Conference report H. Rept. 114-669 filed.</text>
      <reference ref="CR H4392-4419" label="text of conference report"/>
    </action>
    <action datetime="2016-07-07T00:22:54-04:00">
      <text>Rules Committee Resolution H. Res. 809 Reported to House. Rule provides for consideration of the conference report to S. 524 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit. Sec. 2 provides that upon adoption of the resolution, the House shall be considered to have taken S. 2943 from the Speaker's table, stricken all after the enacting clause and inserted the provisions of H.R. 4909 as passed by the House. S. 2943 shall be considered as passed as amended. It shall also be in order for the Chair of the Committee on Armed services to move that the House insist on its amendment to S. 2943 and request a conference with the Senate thereon.</text>
    </action>
    <action datetime="2016-07-07T17:56:10-04:00">
      <text>Rule H. Res. 809 passed House.</text>
    </action>
    <action datetime="2016-07-08T10:44:09-04:00">
      <text>CALLING UP CONFERENCE REPORT - Pursuant to the provisions of H. Res. 809, the Chair recognized Mr. Upton for the purpose of calling up the conference report to accompany S. 524.</text>
    </action>
    <action datetime="2016-07-08T10:44:18-04:00">
      <text>Mr. Upton brought up conference report H. Rept. 114-669 for consideration as a privileged matter.</text>
      <reference ref="CR H4554-4561" label="consideration"/>
    </action>
    <action datetime="2016-07-08T10:44:20-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on the conference report to accompany S. 524.</text>
    </action>
    <action datetime="2016-07-08T11:36:20-04:00">
      <text>The previous question was ordered pursuant to the rule.</text>
      <reference ref="CR H4561" label="consideration"/>
    </action>
    <vote how="roll" type="conference" roll="399" datetime="2016-07-08T11:57:58-04:00" where="h" result="pass" state="CONFERENCE:PASSED:HOUSE">
      <text>On agreeing to the conference report Agreed to by the Yeas and Nays: 407 - 5 (Roll No. 399).</text>
      <reference ref="CR H4561" label="consideration"/>
    </vote>
    <action datetime="2016-07-08T11:57:59-04:00">
      <text>Motions to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2016-07-11">
      <text>Conference papers: Senate report and manager's statement and message on House action held at the desk in Senate.</text>
    </action>
    <action datetime="2016-07-11">
      <text>Conference report considered in Senate.</text>
      <reference ref="CR S4926-4929" label="consideration"/>
    </action>
    <action datetime="2016-07-11">
      <text>Cloture motion on the conference report to accompany S. 524 presented in Senate.</text>
      <reference ref="CR S4926" label="consideration"/>
      <reference ref="CR S4926" label="text"/>
    </action>
    <action datetime="2016-07-12">
      <text>Conference report considered in Senate.</text>
      <reference ref="CR S4955-4962, S4975-4993" label="consideration"/>
    </action>
    <action datetime="2016-07-13">
      <text>Conference report considered in Senate.</text>
      <reference ref="CR S5022-5028, S5045-5058, S5058-5066" label="consideration"/>
    </action>
    <action datetime="2016-07-13">
      <text>Cloture on the conference report to accompany S. 524 invoked in Senate by Yea-Nay Vote. 90 - 2. Record Vote Number: 126.</text>
      <reference ref="CR S5027-5028" label="consideration"/>
      <reference ref="CR S5027" label="text"/>
    </action>
    <vote how="roll" type="conference" roll="129" datetime="2016-07-13" where="s" result="pass" state="PASSED:BILL">
      <text>Senate agreed to conference report to accompany S. 524 by Yea-Nay Vote. 92 - 2. Record Vote Number: 129.</text>
    </vote>
    <action datetime="2016-07-13">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <topresident datetime="2016-07-14">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2016-07-22" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="114-198" type="public" datetime="2016-07-22">
      <text>Became Public Law No: 114-198.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Reporting, Markup, Hearings, Referral"/>
  </committees>
  <relatedbills>
    <bill session="114" type="h" number="953" relation="identical"/>
    <bill session="114" type="h" number="2463" relation="unknown"/>
    <bill session="114" type="h" number="4641" relation="unknown"/>
    <bill session="114" type="s" number="32" relation="unknown"/>
    <bill session="114" type="s" number="1913" relation="unknown"/>
    <bill session="114" type="h" number="4876" relation="unknown"/>
    <bill session="114" type="s" number="2256" relation="unknown"/>
    <bill session="114" type="h" number="5249" relation="unknown"/>
    <bill session="114" type="s" number="2678" relation="unknown"/>
    <bill session="114" type="h" number="1725" relation="unknown"/>
    <bill session="114" type="h" number="1818" relation="unknown"/>
    <bill session="114" type="h" number="3380" relation="unknown"/>
    <bill session="114" type="h" number="3680" relation="unknown"/>
    <bill session="114" type="h" number="3691" relation="unknown"/>
    <bill session="114" type="h" number="4063" relation="unknown"/>
    <bill session="114" type="h" number="4586" relation="unknown"/>
    <bill session="114" type="h" number="4599" relation="unknown"/>
    <bill session="114" type="h" number="4843" relation="unknown"/>
    <bill session="114" type="s" number="2914" relation="unknown"/>
    <bill session="114" type="hr" number="809" relation="procedurally-related"/>
    <bill session="114" type="h" number="4892" relation="unknown"/>
    <bill session="114" type="h" number="4976" relation="unknown"/>
    <bill session="114" type="h" number="4978" relation="unknown"/>
    <bill session="114" type="h" number="4981" relation="unknown"/>
    <bill session="114" type="h" number="4985" relation="unknown"/>
    <bill session="114" type="h" number="5046" relation="unknown"/>
    <bill session="114" type="h" number="5048" relation="unknown"/>
    <bill session="114" type="h" number="5052" relation="unknown"/>
    <bill session="114" type="h" number="4969" relation="unknown"/>
    <bill session="114" type="h" number="4982" relation="unknown"/>
    <bill session="114" type="s" number="3015" relation="unknown"/>
    <bill session="114" type="s" number="2872" relation="unknown"/>
    <bill session="114" type="hr" number="725" relation="procedurally-related"/>
    <bill session="114" type="h" number="5145" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Advisory bodies"/>
    <term name="Alternative treatments"/>
    <term name="Child health"/>
    <term name="Child safety and welfare"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Correctional facilities and imprisonment"/>
    <term name="Crime prevention"/>
    <term name="Criminal investigation, prosecution, interrogation"/>
    <term name="Criminal procedure and sentencing"/>
    <term name="Department of Veterans Affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Education programs funding"/>
    <term name="Elementary and secondary education"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Employee hiring"/>
    <term name="Employee performance"/>
    <term name="Family services"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health care quality"/>
    <term name="Health facilities and institutions"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Higher education"/>
    <term name="Home and outpatient care"/>
    <term name="Internet and video services"/>
    <term name="Internet, web applications, social media"/>
    <term name="Juvenile crime and gang violence"/>
    <term name="Law enforcement administration and funding"/>
    <term name="Law enforcement officers"/>
    <term name="Licensing and registrations"/>
    <term name="Medicaid"/>
    <term name="Medical ethics"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Mental health"/>
    <term name="Military medicine"/>
    <term name="Prescription drugs"/>
    <term name="Teaching, teachers, curricula"/>
    <term name="Veterans' education, employment, rehabilitation"/>
    <term name="Veterans' medical care"/>
    <term name="Vocational and technical education"/>
    <term name="Women's health"/>
  </subjects>
  <amendments>
    <amendment number="s3449"/>
    <amendment number="s3448"/>
    <amendment number="s3446"/>
    <amendment number="s3445"/>
    <amendment number="s3444"/>
    <amendment number="s3443"/>
    <amendment number="s3442"/>
    <amendment number="s3441"/>
    <amendment number="s3440"/>
    <amendment number="s3439"/>
    <amendment number="s3438"/>
    <amendment number="s3437"/>
    <amendment number="s3436"/>
    <amendment number="s3435"/>
    <amendment number="s3434"/>
    <amendment number="s3433"/>
    <amendment number="s3432"/>
    <amendment number="s3431"/>
    <amendment number="s3430"/>
    <amendment number="s3429"/>
    <amendment number="s3428"/>
    <amendment number="s3426"/>
    <amendment number="s3425"/>
    <amendment number="s3424"/>
    <amendment number="s3423"/>
    <amendment number="s3422"/>
    <amendment number="s3421"/>
    <amendment number="s3420"/>
    <amendment number="s3419"/>
    <amendment number="s3418"/>
    <amendment number="s3417"/>
    <amendment number="s3416"/>
    <amendment number="s3415"/>
    <amendment number="s3414"/>
    <amendment number="s3413"/>
    <amendment number="s3412"/>
    <amendment number="s3411"/>
    <amendment number="s3410"/>
    <amendment number="s3409"/>
    <amendment number="s3408"/>
    <amendment number="s3407"/>
    <amendment number="s3406"/>
    <amendment number="s3405"/>
    <amendment number="s3404"/>
    <amendment number="s3403"/>
    <amendment number="s3402"/>
    <amendment number="s3401"/>
    <amendment number="s3400"/>
    <amendment number="s3399"/>
    <amendment number="s3398"/>
    <amendment number="s3397"/>
    <amendment number="s3396"/>
    <amendment number="s3395"/>
    <amendment number="s3394"/>
    <amendment number="s3393"/>
    <amendment number="s3392"/>
    <amendment number="s3391"/>
    <amendment number="s3390"/>
    <amendment number="s3389"/>
    <amendment number="s3388"/>
    <amendment number="s3387"/>
    <amendment number="s3386"/>
    <amendment number="s3385"/>
    <amendment number="s3384"/>
    <amendment number="s3383"/>
    <amendment number="s3382"/>
    <amendment number="s3381"/>
    <amendment number="s3380"/>
    <amendment number="s3379"/>
    <amendment number="s3378"/>
    <amendment number="s3377"/>
    <amendment number="s3376"/>
    <amendment number="s3375"/>
    <amendment number="s3374"/>
    <amendment number="s3373"/>
    <amendment number="s3372"/>
    <amendment number="s3371"/>
    <amendment number="s3370"/>
    <amendment number="s3369"/>
    <amendment number="s3368"/>
    <amendment number="s3367"/>
    <amendment number="s3366"/>
    <amendment number="s3365"/>
    <amendment number="s3364"/>
    <amendment number="s3363"/>
    <amendment number="s3362"/>
    <amendment number="s3361"/>
    <amendment number="s3360"/>
    <amendment number="s3359"/>
    <amendment number="s3358"/>
    <amendment number="s3357"/>
    <amendment number="s3356"/>
    <amendment number="s3355"/>
    <amendment number="s3354"/>
    <amendment number="s3353"/>
    <amendment number="s3352"/>
    <amendment number="s3351"/>
    <amendment number="s3350"/>
    <amendment number="s3349"/>
    <amendment number="s3348"/>
    <amendment number="s3347"/>
    <amendment number="s3346"/>
    <amendment number="s3345"/>
    <amendment number="s3344"/>
    <amendment number="s3343"/>
    <amendment number="s3342"/>
    <amendment number="s3341"/>
    <amendment number="s3340"/>
    <amendment number="s3339"/>
    <amendment number="s3338"/>
    <amendment number="s3337"/>
    <amendment number="s3336"/>
    <amendment number="s3335"/>
    <amendment number="s3334"/>
    <amendment number="s3333"/>
    <amendment number="s3332"/>
    <amendment number="s3331"/>
    <amendment number="s3330"/>
    <amendment number="s3329"/>
    <amendment number="s3328"/>
    <amendment number="s3327"/>
    <amendment number="s3326"/>
    <amendment number="h1009"/>
  </amendments>
  <summary date="2018-08-08T21:45:44Z" status="Passed Senate amended">Comprehensive Addiction and Recovery Act of 2016

TITLE I--PREVENTION AND EDUCATION

(Sec. 101) This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration , to convene a Pain Management Best Practices Interagency Task Force to review, modify, and update best practices for pain management and prescription of pain medication. The task force does not have rulemaking authority.

(Sec. 102) It directs HHS to promote education and awareness of prescription opioid abuse. Such education and training must include information on the dangers, prevention, and early warning signs of opioid abuse. (Opioids are drugs with effects similar to opium, such as certain prescription pain medication, fentanyl [a synthetic opioid], and heroin.)

The Office of National Drug Control Policy must establish a national drug awareness campaign that addresses the similarities between opioids and heroin, the link between prescription opioid abuse and heroin use, and the dangerous effects of mixing fentanyl with heroin.

(Sec. 103) The bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize HHS to award grants to community-based coalitions to enhance community-wide prevention strategies to address a high rate or rapid increase of opioid or methamphetamine abuse.

TITLE II--LAW ENFORCEMENT AND TREATMENT

(Sec. 201) HHS may award grants to state, local, or tribal governments or nonprofit organizations to develop, implement, or expand treatment alternative to incarceration programs and to enhance state criminal justice and substance abuse agency collaboration to address prescription opioid abuse and heroin use. HHS must give priority to joint applications from criminal justice and substance abuse agencies and applications from states that provide civil liability protection for trained first responders, health professionals, or family members who administer an opioid overdose reversal drug (e.g., naloxone) to counteract opioid overdose.

(Sec. 202) HHS may award grants to state, local, or tribal governments to allow appropriately trained first responders to administer an opioid overdose reversal drug to treat an opioid overdose. Grant funds must be used to equip first responders with opioid overdose reversal drugs, train first responders to administer such drugs, and develop protocols to refer overdose victims to appropriate treatment. HHS must provide technical assistance and training grants. At least 25% of grant funds must be awarded to entities in rural areas with limited access to emergency medical services.

(Sec. 203) The Department of Justice (DOJ) must expand or make available disposal sites for unwanted prescription medications.

(Sec. 204) DOJ may make grants to state law enforcement agencies to investigate illicit activities related to: (1) heroin, fentanyl, or unlawful prescription opioid distribution, and (2) precursor diversion, laboratories, or methamphetamine manufacture or distribution.

TITLE III--TREATMENT AND RECOVERY

(Sec. 301) The bill authorizes the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to state, local, or tribal governments or community-based organizations to expand treatment programs, including medication-assisted treatment programs, in areas with a high rate or rapid increase in prescription opioid or heroin use. SAMHSA must equitably distribute grants geographically, evaluate grant-supported activities, and provide technical assistance.

(Sec. 302) HHS may award grants to state, local, or tribal governments to implement medication-assisted treatment programs through courts, prisons, jails, or other criminal justice agencies. HHS must prioritize entities in states that provide civil liability protection for trained first responders, health professionals, or family members who administer naloxone to counteract opioid overdose. Additionally, HHS must provide technical assistance and training to grant recipients.

(Sec. 303) HHS may award grants to high schools, institutions of higher education, or nonprofit organizations to provide recovery support services, build supportive communities, and promote sustained recovery for young people with substance use disorders.

(Sec. 304) HHS may award matching grants to recovery community organizations to expand, develop, and enhance state and community recovery support services to facilitate long-term recovery from substance use disorders. A recovery community organization is an independent nonprofit organization that is led by individuals who are in long-term recovery from substance abuse disorders.

TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES

(Sec. 401) The bill authorizes DOJ to award grants to state, local, or tribal governments to design, implement, and expand educational programs for offenders in prisons, jails, and juvenile facilities. A grant recipient may restrict prisoners' Internet access to ensure public safety.

(Sec. 402) DOJ must establish a bipartisan Task Force on Recovery and Collateral Consequences to identify collateral consequences imposed on convicted drug offenders who are in recovery for a substance use disorder and develop and submit legislative and regulatory recommendations to modify such collateral consequences. A collateral consequence is a penalty imposed as a result of a criminal conviction but not as part of the court judgment.

TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND VETERANS

(Sec. 501) The bill authorizes SAMHSA to create a pilot program to award competitive grants to state substance abuse agencies to support family-based services for pregnant and postpartum women with a substance use disorder, address gaps in services provided to women in non-residential based settings, and encourage evidence-based services. The Center for Behavioral Health Statistics and Quality must evaluate the pilot program and report to Congress.

(Sec. 502) DOJ must annually report the number of grant awards under the Family-Based Adult Offender Substance Abuse Treatment Program and how such grants are used for family-based substance abuse treatment programs that serve as an alternative to incarceration for custodial parent drug offenders.

TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS OPIOID AND HEROIN ABUSE

(Sec. 601) DOJ may award grants to states to establish and implement a comprehensive response to opioid abuse that includes prevention and education efforts, a prescription drug monitoring program, prescription drug and opioid addiction treatment programs, and overdose death prevention programs. DOJ must give priority to states that: (1) provide civil liability protection for trained first responders, health professionals, or family members who administer naloxone; (2) do not terminate Medicaid eligibility for individuals who are incarcerated for less than two years; (3) enroll incarcerated drug offenders in community-based treatment services prior to reentry; and (4) record, share, or analyze data from prescription drug monitoring database to identify potential abuse.

TITLE VII--MISCELLANEOUS

(Sec. 701) The Government Accountability Office must report to Congress on how the Medicaid institutions for mental disease (IMD) exclusion impacts access to inpatient treatment and quality of inpatient and outpatient treatment for Medicaid enrollees with substance use disorders. The Medicaid IMD exclusion bars Medicaid reimbursement for certain inpatient mental health care services (including substance use disorder treatment) for patients aged 21 to 64.

(Sec. 702) The bill authorizes addiction and recovery programs under this Act through FY2020.

(Sec. 704) It prohibits the use of DOJ and HHS grants under this Act for conferences that cost more than $20,000 without prior written approval. The Inspector General for DOJ and HHS must conduct annual audits of selected grant recipients. It bars DOJ and HHS grants to nonprofit organizations that hold money in an offshore account to avoid tax liability. Additionally, DOJ and HHS must identify and report on duplicative grant awards.

(Sec. 705) This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize a Medicare prescription drug plan (PDP) sponsor to establish a drug management program to limit the prescribers and pharmacies who provide frequently abused drugs to an at-risk beneficiary. A PDP sponsor must have in place a utilization management tool to prevent drug abuse.

A PDP sponsor must: (1) notify a beneficiary who is identified as being at-risk for prescription drug abuse, (2) consider the beneficiary's preferences in selecting allowable prescribers and pharmacies, and (3) ensure the beneficiary has continued reasonable access to drugs.

The bill exempts from identification as at-risk beneficiary an individual who is receiving hospice care or residing in a long-term care facility.

HHS must establish procedures for PDP plan sponsors to share information about at-risk beneficiaries.

TITLE VIII--TRANSNATIONAL DRUG TRAFFICKING ACT

Transnational Drug Trafficking Act of 2015

(Sec. 802) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. (Sec. 803) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</summary>
  <committee-reports>
    <report>H. Rept. 114-669</report>
  </committee-reports>
</bill>
